• Je něco špatně v tomto záznamu ?

Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction

M. Pavkova Goldbergova, J. Jarkovsky, J. Lipkova, S. Littnerova, M. Poloczek, J. Spinar, L. Kubkova, K. Kluz, P. Kala, J. Manousek, A. Vasku, J. Parenica,

. 2017 ; 58 (3) : 331-341. [pub] 20170118

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031121

The influence of polymorphisms in the large group of MMP and TIMP genes on clinical outcomes in patients after ST elevation myocardial infarction (STEMI) treated with primary PCI was analysed. In total, 550 consecutive Caucasian patients with STEMI were included in the present study, with a median of 32 months. We analysed 19 polymorphisms in the genes coding MMP and TIMP genes. The MMP-1 -519A/G and -422A/T polymorphisms are associated with combined endpoint after myocardial infarction. The hazard ratio for AT variant of MMP-1 -422A/T was 1.75 (p < 0.001); the variants with at least one A allele of MMP-1 -519A/G have less risk of combined endpoint. The TT variants of -1562C/T MMP-9 and at least one T allele of +92C/T MMP-13 were considered in a trend to affect disease progression and long-term survival after myocardial infarction. According to reclassification analysis NRI and IDI, long-term risk stratification using MMP-1 -422A/T and -519A/G polymorphisms gives additional information to the commonly used GRACE risk score. Patient stratification after myocardial infraction (MI) according to risk genotypes of MMP-1 polymorphisms could have important clinical implications for identification of patients at risk and therapeutic strategies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031121
003      
CZ-PrNML
005      
20200720084457.0
007      
ta
008      
171025s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13353-016-0388-8 $2 doi
035    __
$a (PubMed)28101856
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pavkova Goldbergova, Monika $u Faculty of Medicine, Masaryk University, Brno, Czech Republic.
245    10
$a Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction / $c M. Pavkova Goldbergova, J. Jarkovsky, J. Lipkova, S. Littnerova, M. Poloczek, J. Spinar, L. Kubkova, K. Kluz, P. Kala, J. Manousek, A. Vasku, J. Parenica,
520    9_
$a The influence of polymorphisms in the large group of MMP and TIMP genes on clinical outcomes in patients after ST elevation myocardial infarction (STEMI) treated with primary PCI was analysed. In total, 550 consecutive Caucasian patients with STEMI were included in the present study, with a median of 32 months. We analysed 19 polymorphisms in the genes coding MMP and TIMP genes. The MMP-1 -519A/G and -422A/T polymorphisms are associated with combined endpoint after myocardial infarction. The hazard ratio for AT variant of MMP-1 -422A/T was 1.75 (p < 0.001); the variants with at least one A allele of MMP-1 -519A/G have less risk of combined endpoint. The TT variants of -1562C/T MMP-9 and at least one T allele of +92C/T MMP-13 were considered in a trend to affect disease progression and long-term survival after myocardial infarction. According to reclassification analysis NRI and IDI, long-term risk stratification using MMP-1 -422A/T and -519A/G polymorphisms gives additional information to the commonly used GRACE risk score. Patient stratification after myocardial infraction (MI) according to risk genotypes of MMP-1 polymorphisms could have important clinical implications for identification of patients at risk and therapeutic strategies.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a alely $7 D000483
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a matrixová metaloproteinasa 1 $x genetika $7 D020781
650    _2
$a matrixová metaloproteinasa 13 $x genetika $7 D053509
650    _2
$a matrixová metaloproteinasa 9 $x genetika $7 D020780
650    _2
$a lidé středního věku $7 D008875
650    _2
$a koronární angioplastika $7 D062645
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a prognóza $7 D011379
650    _2
$a rizikové faktory $7 D012307
650    _2
$a infarkt myokardu s elevacemi ST úseků $x diagnóza $x genetika $7 D000072657
650    _2
$a tkáňové inhibitory metaloproteinas $x genetika $7 D019714
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jarkovsky, Jiri $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
700    1_
$a Lipkova, Jolana $u Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Littnerova, Simona $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
700    1_
$a Poloczek, Martin $u Faculty of Medicine, Masaryk University, Brno, Czech Republic. Cardiology Department, Faculty Hospital Brno, Brno, Czech Republic.
700    1_
$a Spinar, Jindrich $u Faculty of Medicine, Masaryk University, Brno, Czech Republic. Cardiology Department, Faculty Hospital Brno, Brno, Czech Republic. International Clinical Research Center - Department of Cardiovascular Disease, University Hospital St. Annes's, Brno, Czech Republic.
700    1_
$a Kubkova, Lenka $u Faculty of Medicine, Masaryk University, Brno, Czech Republic. Cardiology Department, Faculty Hospital Brno, Brno, Czech Republic. International Clinical Research Center - Department of Cardiovascular Disease, University Hospital St. Annes's, Brno, Czech Republic.
700    1_
$a Kluz, Krystyna $u Faculty of Medicine, Masaryk University, Brno, Czech Republic. Hospital Podlesi a.s., Trinec, Czech Republic. $7 xx0243485
700    1_
$a Kala, Petr $u Faculty of Medicine, Masaryk University, Brno, Czech Republic. Cardiology Department, Faculty Hospital Brno, Brno, Czech Republic.
700    1_
$a Manousek, Jan $u Faculty of Medicine, Masaryk University, Brno, Czech Republic. Cardiology Department, Faculty Hospital Brno, Brno, Czech Republic.
700    1_
$a Vasku, Anna $u Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Parenica, Jiri $u Faculty of Medicine, Masaryk University, Brno, Czech Republic. jiri.parenica@atlas.cz. Cardiology Department, Faculty Hospital Brno, Brno, Czech Republic. jiri.parenica@atlas.cz. International Clinical Research Center - Department of Cardiovascular Disease, University Hospital St. Annes's, Brno, Czech Republic. jiri.parenica@atlas.cz. Cardiology Department, University Hospital Brno, Jihlavska 20, Brno, 625 00, Czech Republic. jiri.parenica@atlas.cz.
773    0_
$w MED00002521 $t Journal of applied genetics $x 2190-3883 $g Roč. 58, č. 3 (2017), s. 331-341
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28101856 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20200720084457 $b ABA008
999    __
$a ok $b bmc $g 1254714 $s 992148
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 58 $c 3 $d 331-341 $e 20170118 $i 2190-3883 $m Journal of Applied Genetics $n J Appl Genet $x MED00002521
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace